Cite
Arnone CM, Polito VA, Mastronuzzi A, et al. Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas. J Immunother Cancer. 2021;9(5)doi: 10.1136/jitc-2020-001930.
Arnone, C. M., Polito, V. A., Mastronuzzi, A., Carai, A., Diomedi, F. C., Antonucci, L., Petrilli, L. L., Vinci, M., Ferrari, F., Salviato, E., Scarsella, M., De Stefanis, C., Weber, G., Quintarelli, C., De Angelis, B., Brenner, M. K., Gottschalk, S., Hoyos, V., Locatelli, F., Caruana, I., & Del Bufalo, F. (2021). Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas. Journal for immunotherapy of cancer, 9(5), . https://doi.org/10.1136/jitc-2020-001930
Arnone, Claudia Manuela, et al. "Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas." Journal for immunotherapy of cancer vol. 9,5 (2021). doi: https://doi.org/10.1136/jitc-2020-001930
Arnone CM, Polito VA, Mastronuzzi A, Carai A, Diomedi FC, Antonucci L, Petrilli LL, Vinci M, Ferrari F, Salviato E, Scarsella M, De Stefanis C, Weber G, Quintarelli C, De Angelis B, Brenner MK, Gottschalk S, Hoyos V, Locatelli F, Caruana I, Del Bufalo F. Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas. J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-001930. PMID: 33963009; PMCID: PMC8108682.
Copy
Download .nbib